Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

Abroad (travel likely)Recruiting

Conditions

COVID-19, SARS-CoV-2 Infection · RSV · Influenza

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

VA Portland Health Care System, Portland, OR, Portland, Oregon, United States
Contact: Study coordinator (Kristina L Bajema, MD) · Kristina.Bajema@va.gov · 503-220-8262
Contact: Study coordinator (George N Ioannou, MD MS) · George.Ioannou@va.gov · (206) 277-3136
Contact: Study Chair (Kristina L Bajema, MD)

Study leads

Kristina L Bajema, MD
Study Chair
VA Portland Health Care System, Portland, OR
George N. Ioannou, MD MS
Study Chair
VA Puget Sound Health Care System Seattle Division, Seattle, WA

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Dime La VerDAD: Verify, Debunk, and Disseminate

Influenza · COVID-19 · Communication Research

Abroad (travel likely)Recruiting

Chicago, United States · Chicago, United States

A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

COVID-19

Abroad (travel likely)RecruitingPHASE1

Decatur, United States · Baltimore, United States

The Impact of COVID-19 on Maternal and Neonatal Outcomes

COVID-19 · Pregnancy; Infection

Abroad (travel likely)Recruiting

Baltimore, United States

International Survey of Acute Coronavirus Syndromes-COVID-19

COVID-19

Abroad (travel likely)Recruiting

Bologna, Italy · Barcelona, Spain